-
Cai WT, Li YT, Chen SR, Wang ML, Zhang AD, Zhou HB, Chen HC, Jin ML, 2015: 14-Deoxy-11, 12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes[J]. Antiviral Res, 118, 82-92. doi: 10.1016/j.antiviral.2015.03.008
-
Chen H, Deng G, Li Z, Tian G, Li Y, Jiao P, Zhang L, Liu Z, Webster RG, Yu K, 2004: The evolution of H5N1 influenza viruses in ducks in southern China[J]. Proc Natl Acad Sci U S A, 101, 10452-10457. doi: 10.1073/pnas.0403212101
-
Cheng W, Ren J, Huang Q, Long H, Jin H, Zhang L, Liu H, van Ofwegen L, Lin W, 2016: Pregnane steroids from a gorgonian coral Subergorgia suberosa with anti-flu virus effects[J]. Steroids, 108, 99-104. doi: 10.1016/j.steroids.2016.02.003
-
Cinatl J Jr, Michaelis M, Doerr HW, 2007: The threat of avian influenza A (H5N1)[J]. Part IV: development of vaccines. Med Microbiol Immunol, 196, 213-225.
-
Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Skehel JJ, Martin SR, Hay AJ, Gamblin SJ, 2008: Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants[J]. Nature, 453, 1258-1261. doi: 10.1038/nature06956
-
De Clercq E, 2006: Antiviral agents active against influenza A viruses[J]. Nat Rev Drug Discov, 5, 1015-1025. doi: 10.1038/nrd2175
-
Ding Y, Dou J, Teng Z, Yu J, Wang T, Lu N, Wang H, Zhou C, 2014: Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase[J]. Arch Virol, 159, 3269-3278. doi: 10.1007/s00705-014-2192-2
-
Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL, 2013: Favipiravir (T-705), a novel viral RNA polymerase inhibitor[J]. Antiviral Res, 100, 446-454. doi: 10.1016/j.antiviral.2013.09.015
-
Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y, 2013: Human infection with a novel avian-origin influenza A (H7N9) virus[J]. N Engl J Med, 368, 1888-1897. doi: 10.1056/NEJMoa1304459
-
Hampson AW, 2008: Vaccines for pandemic influenza[J]. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat. Ann Acad Med Singap, 37, 510-517.
-
Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH, 1985: The molecular basis of the specific anti-influenza action of amantadine[J]. EMBO J, 4, 3021-3024. doi: 10.1002/j.1460-2075.1985.tb04038.x
-
Hayden FG, 2006: Antiviral resistance in influenza viruses—Implications for management and pandemic response[J]. N Engl J Med, 354, 785-788. doi: 10.1056/NEJMp068030
-
Hurt AC, 2014: The epidemiology and spread of drug resistant human influenza viruses[J]. Curr Opin Virol, 8, 22-29. doi: 10.1016/j.coviro.2014.04.009
-
Ison MG, 2011: Antivirals and resistance: influenza virus[J]. Curr Opin Virol, 1, 563-573. doi: 10.1016/j.coviro.2011.09.002
-
Jin J, Chen Y, Wang D, Ma L, Guo M, Zhou C, Dou J, 2018: The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza a virus via reduction of neuraminidase activity[J]. Arch Pharm Res, 41, 664-676. doi: 10.1007/s12272-018-1022-6
-
Jung EJ, Lee KH, Seong BL, 2010: Reverse genetic platform for inactivated and live-attenuated influenza vaccine[J]. Exp Mol Med, 42, 116-121. doi: 10.3858/emm.2010.42.2.013
-
Kim JH, Resende R, Wennekes T, Chen HM, Bance N, Buchini S, Watts AG, Pilling P, Streltsov VA, Petric M, Liggins R, Barrett S, McKimm-Breschkin JL, Niikura M, Withers SG, 2013: Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity[J]. Science, 340, 71-75.
-
Koehn FE, Carter GT, 2005: The evolving role of natural products in drug discovery[J]. Nat Rev Drug Discov, 4, 206-220. doi: 10.1038/nrd1657
-
Leang SK, Deng YM, Shaw R, Caldwell N, Iannello P, Komadina N, Buchy P, Chittaganpitch M, Dwyer DE, Fagan P, Gourinat AC, Hammill F, Horwood PF, Huang QS, Ip PK, Jennings L, Kesson A, Kok T, Kool JL, Levy A, Lin C, Lindsay K, Osman O, Papadakis G, Rahnamal F, Rawlinson W, Redden C, Ridgway J, Sam IC, Svobodova S, Tandoc A, Wickramasinghe G, Williamson J, Wilson N, Yusof MA, Kelso A, Barr IG, Hurt AC, 2013: Influenza antiviral resistance in the Asia-Pacific region during 2011[J]. Antiviral Res, 97, 206-210. doi: 10.1016/j.antiviral.2012.12.016
-
Lee SM, Yen HL, 2012: Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection[J]. Antiviral Res, 96, 391-404. doi: 10.1016/j.antiviral.2012.09.013
-
Levine MM, Sztein MB, 2004: Vaccine development strategies for improving immunization: the role of modern immunology[J]. Nat Immunol, 5, 460-464. doi: 10.1038/ni0504-460
-
Rohrs S, Kalthoff D, Beer M, 2014: A model for early onset of protection against lethal challenge with highly pathogenic H5N1 influenza virus[J]. Vaccine, 32, 2631-2636. doi: 10.1016/j.vaccine.2014.03.019
-
Sakai T, Nishimura SI, Naito T, Saito M, 2017: Influenza A virus hemagglutinin and neuraminidase act as novel motile machinery[J]. Sci Rep, 7, 45043-. doi: 10.1038/srep45043
-
Tarbet EB, Hamilton S, Vollmer AH, Luttick A, Ng WC, Pryor M, Hurst BL, Crawford S, Smee DF, Tucker SP, 2014: A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses[J]. J Antimicrob Chemother, 69, 2164-2174. doi: 10.1093/jac/dku127
-
Taubenberger JK, Kash JC, 2010: Influenza virus evolution, host adaptation, and pandemic formation[J]. Cell Host Microb, 7, 440-451. doi: 10.1016/j.chom.2010.05.009
-
Thorlund K, Awad T, Boivin G, Thabane L, 2011: Systematic review of influenza resistance to the neuraminidase inhibitors[J]. BMC Infect Dis, 11, 134-. doi: 10.1186/1471-2334-11-134
-
Tian L, Wang ZY, Wu H, Wang S, Wang Y, Wang YY, Xu JW, Wang LY, Qi FC, Fang ML, Yu DH, Fang XX, 2011: Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo[J]. J Ethnopharmacol, 137, 534-542. doi: 10.1016/j.jep.2011.06.002
-
Yu J, Wang D, Jin J, Xu J, Li M, Wang H, Dou J, Zhou C, 2016: Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase[J]. Antiviral Res, 127, 68-78. doi: 10.1016/j.antiviral.2016.01.011
-
Zhang J, Liu T, Tong X, Li G, Yan J, Ye X, 2012: Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening[J]. Antiviral Res, 93, 48-54. doi: 10.1016/j.antiviral.2011.10.014
-
Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, Kong H, Gu C, Li X, Liu J, Wang G, Chen Y, Liu L, Liang L, Li Y, Fan J, Wang J, Li W, Guan L, Li Q, Yang H, Chen P, Jiang L, Guan Y, Xin X, Jiang Y, Tian G, Wang X, Qiao C, Li C, Bu Z, Chen H, 2013: H7N9 influenza viruses are transmissible in ferrets by respiratory droplet[J]. Science, 341, 410-414. doi: 10.1126/science.1240532
-
Zhou Z, Li XH, Liu JX, Dong L, Chen Q, Liu JL, Kong HH, Zhang QY, Qi X, Hou DX, Zhang L, Zhang GQ, Liu YC, Zhang YJ, Li J, Wang J, Chen X, Wang H, Zhang JF, Chen HL, Zen K, Zhang CY, 2015: Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses[J]. Cell Res, 25, 39-49. doi: 10.1038/cr.2014.130